Profile | GDS4284 / 203082_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2057.79 | 84 |
GSM687648 | Patient 402 control | 2131.55 | 84 |
GSM687653 | Patient 403 control | 3074.25 | 89 |
GSM687658 | Patient 404 control | 1694.79 | 82 |
GSM687663 | Patient 411 control | 2493.55 | 87 |
GSM687668 | Patient 422 control | 2436.91 | 86 |
GSM687673 | Patient 424 control | 1802.8 | 82 |
GSM687678 | Patient 425 control | 2347.32 | 86 |
GSM687683 | Patient 427 control | 1995.65 | 84 |
GSM687688 | Patient 428 control | 2411.45 | 86 |
GSM687695 | Patient 441 control | 1004.38 | 75 |
GSM687699 | Patient 443 control | 1082.19 | 75 |
GSM687704 | Patient 444 control | 2596.61 | 87 |
GSM687707 | Patient 448 control | 2908.1 | 89 |
GSM687712 | Patient 449 control | 1784.5 | 82 |
GSM687719 | Patient 450 control | 1667.94 | 82 |
GSM687724 | Patient 451 control | 2509.79 | 87 |
GSM687728 | Patient 452 control | 1585.17 | 81 |
GSM687646 | Patient 401 treated 24h | 2265.55 | 85 |
GSM687649 | Patient 402 treated 24h | 1652.15 | 81 |
GSM687665 | Patient 411 treated 24h | 2179.64 | 85 |
GSM687651 | Patient 402 treated 4 weeks | 2140.9 | 85 |
GSM687667 | Patient 411 treated 4 weeks | 2512.72 | 87 |
GSM687670 | Patient 422 treated 24h | 2359.6 | 86 |
GSM687671 | Patient 422 treated 4 weeks | 2418.4 | 86 |
GSM687654 | Patient 403 treated 24h | 2579.21 | 87 |
GSM687675 | Patient 424 treated 24h | 2108.62 | 85 |
GSM687685 | Patient 427 treated 24h | 1649.63 | 81 |
GSM687656 | Patient 403 treated 4 weeks | 3060.83 | 89 |
GSM687677 | Patient 424 treated 4 weeks | 2298.47 | 85 |
GSM687687 | Patient 427 treated 4 weeks | 2418.36 | 86 |
GSM687692 | Patient 428 treated 4h | 1857.76 | 83 |
GSM687716 | Patient 449 treated 4h | 1905.28 | 83 |
GSM687722 | Patient 450 treated 4h | 1501.2 | 80 |
GSM687680 | Patient 425 treated 24h | 1839.29 | 83 |
GSM687690 | Patient 428 treated 24h | 1692.37 | 82 |
GSM687700 | Patient 443 treated 24h | 1767.62 | 83 |
GSM687705 | Patient 444 treated 24h | 3017.01 | 89 |
GSM687714 | Patient 449 treated 24h | 2258.95 | 85 |
GSM687721 | Patient 450 treated 24h | 1268.18 | 78 |
GSM687682 | Patient 425 treated 4 weeks | 2073.05 | 84 |
GSM687694 | Patient 428 treated 4 weeks | 2127.33 | 84 |
GSM687702 | Patient 443 treated 4 weeks | 2057.27 | 84 |
GSM687718 | Patient 449 treated 4 weeks | 2466.84 | 87 |
GSM687723 | Patient 450 treated 4 weeks | 1798.62 | 83 |
GSM687661 | Patient 404 treated 4h | 1865.14 | 83 |
GSM687710 | Patient 448 treated 4h | 3112.65 | 89 |
GSM687726 | Patient 451 treated 4h | 2302.33 | 86 |
GSM687730 | Patient 452 treated 4h | 4034.03 | 93 |
GSM687660 | Patient 404 treated 24h | 1027.59 | 76 |
GSM687697 | Patient 441 treated 24h | 1263.69 | 78 |
GSM687709 | Patient 448 treated 24h | 3528.26 | 90 |
GSM687725 | Patient 451 treated 24h | 2201.4 | 85 |
GSM687729 | Patient 452 treated 24h | 1103.51 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 2642.33 | 87 |
GSM687731 | Patient 452 treated 4 weeks | 1624.63 | 81 |